Zoetis Announces Partnership with Arthritis Foundation to Raise Awareness of Osteoarthritis Pain in Pets
Today, in recognition of Pain Awareness Month, Zoetis and the Arthritis Foundation have announced a two-year partnership to raise awareness of and provide educational resources about the most common type of arthritis pain, known as osteoarthritis (OA) pain. While OA in humans is well-known, many people are not aware of how common OA – and the pain it causes – is in cats and dogs.
Revolutionary AI-Powered Blood Analyser by Zoetis to Debut at London Vet Show – See How It’s Changing Veterinary Diagnostics!
Zoetis will unveil its new AI-powered haematology analyser, Vetscan OptiCell™, at the London Vet Show on November 14-15, 2024. This cartridge-based analyser offers reference lab-quality CBC analysis at the point of care, providing significant time, cost, and space savings for veterinary teams. Learn how this innovative tool is set to redefine veterinary diagnostics and improve patient care.
How Dr. Dazjah Samuels is Redefining Veterinary Leadership: Latest Vet Candy Magazine is here!
Discover the inspiring journey of Dr. Dazjah Samuels, a 2024 graduate of Ross University, as she embarks on the path to veterinary leadership with Hometown Veterinary Partners. This month’s Vet Candy magazine, brought to you by Zoetis, also features insights from Dr. Wailani Sung on identifying feline pain, groundbreaking research on gut bacteria in cats, and the latest veterinary lifestyle trends. Available on Vet Candy, Amazon Kindle, and Apple Books.
Zoetis, IDEXX, and Weave Report Strong Q2 2024 Earnings, Announce Growth Strategies
The veterinary and healthcare sectors saw significant activity this quarter as Zoetis, IDEXX Laboratories, and Weave all reported robust financial results, underscoring their continued growth and strategic advancements.
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation(Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
Revolutionizing Feline Care: Say Goodbye to Cat Anxiety with Bonqat®
Discover Bonqat®, the groundbreaking anxiety solution for cats by Zoetis. Learn how this innovative medication is transforming feline care, easing travel and vet visit stress. Say goodbye to cat anxiety with Bonqat® - the ultimate solution every pet owner needs!